PharmaCyte Legal|Restructuring Thursday, November 19, 2026 -0.50 Negative

PharmaCyte exchanges warrants for shares and extends maturity

PharmaCyte Biotech will exchange 851,304 warrants for 4,982,272 shares and has agreed to extend the Series H preferred stock maturity. The extension was secured via the consent of the holder, who controls a majority of the Series H stock.

View original filing at SEC.gov →
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

START FREE — 10,000 calls/day, no key needed